(Q54109428)

English

Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2475012

Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid. (English)

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2475012

cerebrospinal fluid

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

B Mårtensson

1

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2475012

S Nyberg

2

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2475012

G Toresson

3

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2475012

E Brodin

4

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2475012

L Bertilsson

5

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2475012

language of work or name

0 references

publication date

1 June 1989

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2475012

Acta Psychiatrica Scandinavica

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2475012

79

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2475012

586-596

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2475012

6

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2475012

Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1989.TB10307.X

21 January 2018

Serotonin and substance P coexist in neurons of the rat's central nervous system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1989.TB10307.X

21 January 2018

Immunohistochemical evidence of substance P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the rat central nervous system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1989.TB10307.X

21 January 2018

Perturbation of Rat Brain Serotonergic Systems Results in an Inverse Relation Between Substance P and Serotonin Concentrations Measured in Discrete Nuclei

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1989.TB10307.X

21 January 2018

Monoaminergic modulation of the sensitivity of neurones in the cingulate cortex to iontophoretically applied substance P

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1989.TB10307.X

21 January 2018

Tachykinin multiplicity in rat central nervous system as studied using antisera raised against substance P and neurokinin A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1989.TB10307.X

21 January 2018

Binding of tricyclic antidepressants and perazine to human plasma. Methodology and findings in normals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1989.TB10307.X

21 January 2018

Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1989.TB10307.X

21 January 2018

Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1989.TB10307.X

21 January 2018

Controlled study comparing nomifensine and clomipramine in unipolar depression, using the probenecid technique

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1989.TB10307.X

21 January 2018

Effects of a dopamine agonist piribedil in depressed patients: relationship of pretreatment homovanillic acid to antidepressant response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1989.TB10307.X

21 January 2018

Biological and behavioral effects of one night's sleep deprivation in depressed patients and normals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1989.TB10307.X

21 January 2018

Noradrenergic inhibition of the release of substance P from the primary afferents in the rabbit spinal dorsal horn.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1989.TB10307.X

21 January 2018

Bupropion in depression. I. Biochemical effects and clinical response.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1989.TB10307.X

21 January 2018

Mode of action of antidepressant drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1989.TB10307.X

21 January 2018

Therapeutic indications for serotonin-potentiating compounds: a hypothesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1989.TB10307.X

21 January 2018

Identifiers

10.1111/J.1600-0447.1989.TB10307.X

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2475012

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/2475012

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54109428&oldid=1786028071"